Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Dose-finding Study of E7050 Administered Orally to Patients With Advanced Solid Tumors.

NCT00921869 is registered in ClinicalTrials.gov with Eisai Co., Ltd. as lead sponsor.

NCT NCT00921869
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00921869 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Dose-finding Study of E7050 Administered Orally to Patients With Advanced Solid Tumors.
Lead sponsor
Eisai Co., Ltd.
Phase
Phase 1
Overall status
Completed
Start date
October 31, 2009
Completion date
June 30, 2011
Enrollment
16 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

solid tumors